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Nodular thyroid disease is 
common throughout the 
world, and the incidence has 
been rising in recent decades. 
Worldwide, thyroid nodules 
have been reported in 4 - 7% of the popula-
tion on neck palpation and in 30 - 50% when 
investigated by ultrasonography.[1,2] Usually 
patients with nodular thyroid disease present 
to a surgical clinic with a neck mass, with 
or without toxic symptoms, with pressure 
symptoms or for cosmetic reasons. Treatment 
options depend on the cause and the clinical 
presentation and include medication, radio-
active iodine and surgery.
Thyroid nodules can be benign (adenoma, 
nodules of multinodular goitres (MNGs), or 
localised thyroiditis, including autoimmune 
disease and cysts) or malignant (papillary 
adenocarcinoma, follicular adenocarcinoma, 
medullary carcinoma, undifferentiated carci-
noma or lymphoma).
In the hands of experienced surgeons, 
surgery for nodular thyroid disease has low 
mortality and morbidity.[3] Operations include 
lobectomy/hemithyroidectomy, subtotal 
thyroidectomy and total thyroidectomy.
There has been no formal study on these 
diseases in Limpopo Province, South Africa 
(SA), which has a population of 5.5 million.
Objectives
To review the profile of thyroid disease 
in patients with goitre who presented to 
the Department of Surgery at Polokwane 
Mankweng Hospital Complex (PMHC), 
tertiary hospitals in Limpopo, to characterise 
the pattern of malignant disease in patients 
presenting with goitre, and to determine 
the most common thyroid cancer in the 
Limpopo population study group.
Methods
A 6-year retrospective study (2003 - 2008) of all 
patients with thyroid nodules who underwent 
thyroid surgery at PMHC was done. All the 
patient files were reviewed, and cases in which 
histological results were not available were 
excluded. Data were collected from the theatre 
and hospital information systems, the National 
Health Laboratory Service and the patient files.
Results
Of 117 patient files, 27 lacked histological 
results and were excluded from the study. 
The study group therefore consisted of 90 
patients, ranging in age from 4 to 80 years 
(mean 45); 85 (94.4%) were women and 5 
men (5.6%) (male-to-female ratio 17:1).
Thyroid function tests were done in all 
cases, ultrasound scans in 42, isotope nuclear 
scans in 59 and fine-needle aspiration 
cytology (FNAC) in 11. The histopathological 
diagnoses in all 90 patients are shown 
in Table 1. Indications for surgery were 
cosmetic reasons, suspected malignancy, and 
compression of adjacent areas.
Surgical operations included 53 lobec-
tomies, 31 subtotal thyroidectomies and 
6 total thyroidectomies. There were no 
operative deaths. Ten patients (11.1% of 
the total) had malignant lesions (7 follicular 
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Table 1. Histopathological diagnoses of 
thyroid lesions (N=90)
Histological findings
Patients
n (%)
Benign conditions
Adenoma 52 (57.8)
MNG 25 (27.8)
Hyperplastic nodules 2 (2.2)
Hashimoto’s thyroiditis 1 (1.1)
Subtotal 80 (88.9)
Malignant conditions
Follicular carcinoma 7 (7.8)
Papillary carcinoma 3 (3.3)
Subtotal 10 (11.1)
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carcinomas and 3 papillary carcinomas). There were 80 patients 
(88.9%) with benign lesions, of which 52 (57.8% of the total) were 
adenomas, 25 (27.8%) MNGs, 2 (2.2%) hyperplastic nodules and 1 
(1.1%) Hashimoto’s thyroiditis. Two papillary carcinomas were found 
in MNGs (8.0% of MNGs).
Of all the patients, 7.8% had follicular carcinoma (7 cases). 
Adenomas and MNGs were the most common non-malignant 
conditions, occurring in 77 patients (85.6%). In our study, thyroid 
nodules, whether benign or malignant, occurred more frequently in 
women (94.4%) than in men. The age group most affected was 41 - 60 
years (Table 2).
Discussion
The prevalence of thyroid nodules is rising globally. According to the 
World Health Organization, at least 1.6 billion people are at risk of 
iodine deficiency disorders, and of these 655 million are affected by 
goitre.[4] Most thyroid nodules are benign. The worldwide prevalence 
of MNG in the general population is estimated to be 4 - 7%, and 
these lesions are often caused by iodine deficiency.[5] The incidence 
of thyroid malignancy ranges from 0.9% to 20.5% in different parts of 
the world.[6,7] Globally, the most common thyroid cancer is papillary 
carcinoma.[8,9] Follicular carcinoma, while relatively less frequent, is 
reported to be more common in iodine-deficient areas where MNG 
is endemic.[10-17]
Thyroid cancer is the most common endocrine carcinoma, and 
the risk factors for malignancy are age <30 or >60 years, male gender 
(8% males v. 4% females),[2,18] and a history of irradiation to the head 
and neck.[19]
Limpopo Province is located far from the sea, and the iodine 
content in the diet is low. Our 11.1% rate of thyroid cancer in 
Limpopo is consistent with the literature.[6,7] In our study, the 
predominant thyroid cancer was follicular carcinoma (7.8% of 
patients), comparable to reports from Durban and Burkina Faso.[20-22] 
The two cancers in MNGs in our study were papillary carcinomas. 
The risk of malignancy in cases of MNG in our study was 8.9%, 
similar to findings reported in the literature of 2 - 12%.[6,8,10,23-27] 
Although there were few males in our study, figures indicate that men 
are at twice the risk of developing cancer compared with females. 
FNAC was not reliable in Limpopo; as a result we could not use it 
regularly, so it is difficult to draw conclusions in this regard. Cytology 
reports for our 11 patients who underwent FNAC fell into categories 
1 - 3 of the Bethesda classification.[28] On histological examination, 
these lesions were found to be non-malignant. The value of FNAC in 
thyroid cancers and thyroid nodules is well established,[29-31] including 
at PMHC. It is known that the rate of false-negative results for FNAC 
ranges from 0.7% to 2.2% if ultrasound-guided FNAC is used,[32,33] 
the rate rising to 44.7% without ultrasonography.[10,21,34-39] FNAC 
significantly reduces the number of unnecessary operations,[30,31,40] 
but the problem of its missing malignant lesions remains unsolved.
Five of our 59 patients who had isotope nuclear scans were suspected 
to have a malignant lesion, but in only one case was carcinoma 
histologically confirmed, which is similar to previously reported 
findings.[41] Radioisotope investigations for malignant disease have 
an important role, but only if they are taken together with clinical 
findings and other investigations such as ultrasonography, FNAC, 
computed tomography, magnetic resonance imaging or positron 
emission tomography.[7,42]
Benign thyroid disorders are common, and often affect younger 
females. Subtotal thyroidectomy/hemithyroidectomy are the surgical 
procedures most frequently offered.[21,43,44] In our study the majority 
of patients were females, in whom benign conditions predominated; 
the operations performed were either lobectomy or subtotal 
thyroidectomy. 
The approach to the surgical management of benign goitre is 
progressively becoming more radical owing to the risk of recurrent 
goitre[3] and the safety of surgery.[30,45-48] Furthermore, the rate of 
incidental malignancy in MNG is high (8.9% in our study), and 
re-operation for recurrent goitre following subtotal thyroidectomy is 
associated with a significantly increased risk of permanent recurrent 
laryngeal nerve injury.[48]
Conclusions
Adenoma and MNG were the most common non-malignant 
conditions in our study (85.6%). The prevalence of thyroid cancer 
in our study was 11.1%, and of all the lesions 7.8% were follicular 
carcinomas. Malignant lesions were found in 8.9% of patients with 
MNG. We advocate that total thyroidectomy be considered for MNG 
because of the risk of incidental carcinoma.
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